Safety, Tolerance, PK, and Anti-tumour Activity of AZD1775 Monotherapy in Patients With Advanced Solid Tumours

Clinical trial NCT02482311 · COMPLETED

Trial details

NCT number: NCT02482311
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Ovarian Cancer, TNBC, SCLC, Other Solid Tumours

Start date: 2015-07-01
Primary completion: 2018-01-25
Enrollment: 92

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.